CD8A and neoplasm: Having shown that BVax are capable of antigen cross-presentation and expansion of antigen-specific CD8+ T cells, we next looked to evaluate the ability of BVax derived from tumor-bearing mice to activate and expand CD8+ T cells from tumor-bearing mice.